globenewswire

LEXINGTON, Mass. and AMSTERDAM, June 25, 2026 (GLOBE NEWSWIRE) -- uniQure N.V. (Nasdaq: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced the closing of its previously announced underwritten public offering of 5,686,813 ordinary shares at a public offering price of $45.50 per share, which includes 741,758 ordinary shares issued pursuant to the exercise in full by the underwriters of their option to purchase additional ordinary shares in the offering. The aggregate gross proceeds to uniQure from the offering, before deducting the underwriting discounts and commissions and offering expenses payable by uniQure, were approximately $259 million. All securities in the offering were sold by uniQure.

New Educational Resource Explains Product Evaluation Factors, Common Buying Mistakes, Verification Trends, and What Consumers Should Review Before Purchase

RESTON, Va., June 25, 2026 (GLOBE NEWSWIRE) -- Carahsoft Technology Corp., The Trusted Government IT Solutions Provider^®, today announced its human capital technology highlights and initiatives, as well as its upcoming events portfolio for this year, reaffirming its commitment to delivering innovative solutions to the Public Sector.

The rollout includes 2,000+ transit time improvements along with enhanced guaranteed delivery and tracking and logistics capabilities

 ABO-101 is an investigational gene editing therapy designed to address the underlying disease biology of PH1 by reducing hepatic oxalate production

VILNIUS, Lithuania, June 25, 2026 (GLOBE NEWSWIRE) -- WhiteBIT, the largest European exchange by traffic, has launched Crypto Bundles, a new investment product that allows users to gain exposure to portfolios of digital assets built around specific market themes and investment strategies.